Key result
Dantrolene stabilizes the cardiac ryanodine receptor to prevent diastolic calcium leak, showing potential as a treatment for chronic heart failure and ventricular tachycardia storm.
Why the study?
Diastolic Ca2+ leak through destabilized cardiac Ryanodine Receptor (RyR2) promotes heart failure and lethal arrhythmias, warranting discussion of RyR2 stabilizer dantrolene for clinical application.
Does dantrolene improve outcomes in patients with chronic heart failure and VT storm by stabilizing the cardiac ryanodine receptor (RyR2)?
Does dantrolene improve outcomes in patients with chronic heart failure and VT storm by stabilizing the cardiac ryanodine receptor (RyR2)?
Dantrolene shows potential as a novel therapeutic approach for chronic heart failure and VT storm by stabilizing the cardiac ryanodine receptor (RyR2) and preventing diastolic calcium leak.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shigeki Kobayashi (2023) conducted a review in Heart failure and ventricular tachycardia storm. Dantrolene was evaluated. Dantrolene stabilizes the cardiac ryanodine receptor to prevent diastolic calcium leak, showing potential as a treatment for chronic heart failure and ventricular tachycardia storm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: